Spartan Fund Management’s Calidi Biotherapeutics CLDI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,104	Closed	-$3.2M	–	284
2023 Q2	$3.2M	Buy	2,104 +854	+68%	+$1.3M	0.78%	51
2023 Q1	$1.54M	Hold	1,250	–	–	0.72%	44
2022 Q4	$1.53M	Hold	1,250	–	–	0.55%	62
2022 Q3	$1.48M	Buy	+1,250	New	+$1.48M	0.45%	91